AEON Biopharma (AEON) Competitors $0.78 +0.01 (+0.78%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.78 +0.00 (+0.38%) As of 09/12/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEON vs. MDCX, DYAI, IMA, ITRM, BCAB, RNTX, MAAQ, XCUR, RVPH, and KZRShould you be buying AEON Biopharma stock or one of its competitors? The main competitors of AEON Biopharma include Medicus Pharma (MDCX), Dyadic International (DYAI), ImageneBio (IMA), Iterum Therapeutics (ITRM), BioAtla (BCAB), Rein Therapeutics (RNTX), Mana Capital Acquisition (MAAQ), Exicure (XCUR), Reviva Pharmaceuticals (RVPH), and Kezar Life Sciences (KZR). These companies are all part of the "pharmaceutical products" industry. AEON Biopharma vs. Its Competitors Medicus Pharma Dyadic International ImageneBio Iterum Therapeutics BioAtla Rein Therapeutics Mana Capital Acquisition Exicure Reviva Pharmaceuticals Kezar Life Sciences Medicus Pharma (NASDAQ:MDCX) and AEON Biopharma (NASDAQ:AEON) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability. Which has stronger valuation & earnings, MDCX or AEON? Medicus Pharma is trading at a lower price-to-earnings ratio than AEON Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicus PharmaN/AN/A-$11.16M-$1.34-1.80AEON BiopharmaN/AN/A-$36.63M-$6.08-0.13 Do institutionals & insiders believe in MDCX or AEON? 22.8% of AEON Biopharma shares are held by institutional investors. 11.2% of Medicus Pharma shares are held by company insiders. Comparatively, 0.9% of AEON Biopharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor MDCX or AEON? In the previous week, Medicus Pharma had 5 more articles in the media than AEON Biopharma. MarketBeat recorded 8 mentions for Medicus Pharma and 3 mentions for AEON Biopharma. AEON Biopharma's average media sentiment score of 0.66 beat Medicus Pharma's score of -0.13 indicating that AEON Biopharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medicus Pharma 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Neutral AEON Biopharma 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is MDCX or AEON more profitable? AEON Biopharma's return on equity of 0.00% beat Medicus Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Medicus PharmaN/A -549.30% -228.06% AEON Biopharma N/A N/A -994.63% Do analysts prefer MDCX or AEON? Medicus Pharma currently has a consensus target price of $23.50, suggesting a potential upside of 875.10%. AEON Biopharma has a consensus target price of $360.00, suggesting a potential upside of 46,053.85%. Given AEON Biopharma's higher probable upside, analysts plainly believe AEON Biopharma is more favorable than Medicus Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicus Pharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryMedicus Pharma beats AEON Biopharma on 8 of the 13 factors compared between the two stocks. Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEON vs. The Competition Export to ExcelMetricAEON BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.08M$934.71M$5.87B$10.14BDividend YieldN/A4.84%5.68%4.59%P/E Ratio4.331.1074.5225.93Price / SalesN/A26.70548.33126.97Price / CashN/A19.5637.5660.44Price / Book-0.196.6912.166.29Net Income-$36.63M-$4.50M$3.28B$270.77M7 Day Performance2.21%8.75%0.87%3.88%1 Month Performance-2.50%9.50%4.96%4.88%1 Year Performance-98.54%22.47%60.74%26.01% AEON Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEONAEON Biopharma3.1446 of 5 stars$0.78+0.8%$360.00+46,053.8%-98.6%$9.08MN/A4.335News CoveragePositive NewsShort Interest ↓MDCXMedicus Pharma1.7862 of 5 stars$2.09+11.2%$23.50+1,024.4%N/A$33.49MN/A-1.56N/ANews CoverageGap UpDYAIDyadic International2.5836 of 5 stars$0.97+6.1%$6.00+521.7%-22.0%$32.93M$3.42M-5.087Short Interest ↑High Trading VolumeIMAImageneBio3.3507 of 5 stars$9.29+16.7%$35.50+282.1%-55.2%$32M$9.16M-1.2170Positive NewsHigh Trading VolumeITRMIterum Therapeutics2.8487 of 5 stars$0.66-2.6%$9.00+1,263.0%-38.5%$31.99MN/A-0.7810Positive NewsShort Interest ↓BCABBioAtla2.4599 of 5 stars$0.61+13.9%$5.00+718.1%-55.2%$31.50M$11M-0.5660Gap UpHigh Trading VolumeRNTXRein Therapeutics1.0032 of 5 stars$1.34+0.8%N/AN/A$31MN/A-0.509News CoveragePositive NewsGap DownMAAQMana Capital AcquisitionN/A$3.71+0.6%N/A+1,192.7%$30.14MN/A0.001Gap DownXCURExicure1.3709 of 5 stars$4.30-9.5%N/A+153.6%$30.01M$500K-1.1150Positive NewsGap UpRVPHReviva Pharmaceuticals2.9941 of 5 stars$0.45+1.8%$5.20+1,063.3%-60.5%$29.85MN/A-0.695KZRKezar Life Sciences3.8411 of 5 stars$4.01-1.5%$9.00+124.4%-30.3%$29.81M$7M-0.4160High Trading Volume Related Companies and Tools Related Companies MDCX Alternatives DYAI Alternatives IMA Alternatives ITRM Alternatives BCAB Alternatives RNTX Alternatives MAAQ Alternatives XCUR Alternatives RVPH Alternatives KZR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEON) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AEON Stock Alerts